PMC:7243768 / 4813-4923 JSONTXT

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T15","span":{"begin":5,"end":15},"obj":"Chemical"},{"id":"T16","span":{"begin":17,"end":21},"obj":"Chemical"},{"id":"T17","span":{"begin":26,"end":37},"obj":"Chemical"}],"attributes":[{"id":"A15","pred":"chebi_id","subj":"T15","obj":"http://purl.obolibrary.org/obo/CHEBI_35222"},{"id":"A16","pred":"chebi_id","subj":"T16","obj":"http://purl.obolibrary.org/obo/CHEBI_35457"},{"id":"A17","pred":"chebi_id","subj":"T17","obj":"http://purl.obolibrary.org/obo/CHEBI_48433"}],"text":"zyme inhibitors (ACEi) or angiotensin receptor blockers” [10].\nIn response to the above statement, the Europea"}